Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.370
-0.010 (-0.72%)
May 14, 2025, 10:15 AM - Market open
Pliant Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Cash & Equivalents | 91.94 | 71.19 | 63.23 | 33.69 | 51.67 | 50.88 | Upgrade
|
| Short-Term Investments | 213.71 | 284.54 | 431.01 | 297.5 | 148.93 | 226.01 | Upgrade
|
| Cash & Short-Term Investments | 305.65 | 355.72 | 494.25 | 331.19 | 200.6 | 276.89 | Upgrade
|
| Cash Growth | -36.64% | -28.03% | 49.23% | 65.10% | -27.56% | 169.42% | Upgrade
|
| Accounts Receivable | - | - | - | 1.98 | 2 | 9.28 | Upgrade
|
| Other Receivables | 1.68 | 2.3 | 3 | 1.16 | 0.47 | 0.47 | Upgrade
|
| Receivables | 1.68 | 2.3 | 3 | 3.14 | 2.47 | 9.75 | Upgrade
|
| Prepaid Expenses | 1.72 | 2.98 | 4.53 | 4.85 | 5.4 | 3.36 | Upgrade
|
| Other Current Assets | 2.14 | 1.26 | 3.73 | 1.13 | 0.98 | 0.76 | Upgrade
|
| Total Current Assets | 311.19 | 362.26 | 505.5 | 340.31 | 209.44 | 290.75 | Upgrade
|
| Property, Plant & Equipment | 31.67 | 32.77 | 4.78 | 9.91 | 10.94 | 4.32 | Upgrade
|
| Other Long-Term Assets | 1.91 | 1.92 | 1.87 | 0.39 | 0.84 | 0.45 | Upgrade
|
| Total Assets | 344.77 | 396.95 | 512.15 | 350.61 | 221.22 | 295.53 | Upgrade
|
| Accounts Payable | 5.62 | 5.96 | 4.53 | 1.58 | 2.97 | 2.02 | Upgrade
|
| Accrued Expenses | 21.81 | 26.72 | 22.68 | 19.88 | 11.99 | 9.49 | Upgrade
|
| Current Portion of Leases | 0.77 | 0.54 | 1.32 | 2.46 | 1.87 | - | Upgrade
|
| Other Current Liabilities | - | - | - | - | - | 0.09 | Upgrade
|
| Total Current Liabilities | 28.2 | 33.22 | 28.52 | 23.91 | 16.83 | 11.6 | Upgrade
|
| Long-Term Debt | 30.28 | 30.21 | 10.05 | 9.93 | - | - | Upgrade
|
| Long-Term Leases | 29.12 | 29.44 | - | 3.43 | 5.33 | - | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | - | 0.87 | Upgrade
|
| Total Liabilities | 87.61 | 92.87 | 38.58 | 37.27 | 22.16 | 12.47 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 1,023 | 1,014 | 972.97 | 653.71 | 414.35 | 400.92 | Upgrade
|
| Retained Earnings | -766.22 | -710.05 | -499.75 | -338.41 | -215.09 | -117.83 | Upgrade
|
| Comprehensive Income & Other | 0.16 | 0.32 | 0.35 | -1.96 | -0.2 | -0.03 | Upgrade
|
| Total Common Equity | 257.16 | 304.08 | 473.58 | 313.34 | 199.06 | 283.06 | Upgrade
|
| Shareholders' Equity | 257.16 | 304.08 | 473.58 | 313.34 | 199.06 | 283.06 | Upgrade
|
| Total Liabilities & Equity | 344.77 | 396.95 | 512.15 | 350.61 | 221.22 | 295.53 | Upgrade
|
| Total Debt | 60.17 | 60.19 | 11.37 | 15.82 | 7.19 | - | Upgrade
|
| Net Cash (Debt) | 245.47 | 295.53 | 482.87 | 315.37 | 193.4 | 276.89 | Upgrade
|
| Net Cash Growth | -42.61% | -38.80% | 53.11% | 63.07% | -30.15% | 169.42% | Upgrade
|
| Net Cash Per Share | 4.04 | 4.88 | 8.22 | 7.51 | 5.40 | 12.97 | Upgrade
|
| Filing Date Shares Outstanding | 61.39 | 61.24 | 60.24 | 58.94 | 36.11 | 35.74 | Upgrade
|
| Total Common Shares Outstanding | 61.39 | 60.86 | 59.92 | 48.94 | 36.08 | 35.55 | Upgrade
|
| Working Capital | 282.99 | 329.05 | 476.98 | 316.4 | 192.61 | 279.16 | Upgrade
|
| Book Value Per Share | 4.19 | 5.00 | 7.90 | 6.40 | 5.52 | 7.96 | Upgrade
|
| Tangible Book Value | 257.16 | 304.08 | 473.58 | 313.34 | 199.06 | 283.06 | Upgrade
|
| Tangible Book Value Per Share | 4.19 | 5.00 | 7.90 | 6.40 | 5.52 | 7.96 | Upgrade
|
| Machinery | 14.24 | 13.87 | 10.53 | 9.61 | 7.97 | 6.56 | Upgrade
|
| Construction In Progress | 0.13 | 0.35 | 0.05 | 0.07 | 0.04 | 0.3 | Upgrade
|
| Leasehold Improvements | 2.12 | 2.12 | 1.66 | 1.65 | 1.62 | 0.95 | Upgrade
|
Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.